Characterization of a liver metastatic variant of murine colon 26 carcinoma cells

Tumor Biology

Volumn 18, Issue 2, 1997, Pages 113-122

  Ohnishi, Yasuharu ^a,b   Fujii, Hideki ^a   Kimura, Fuminari ^a   Murata, Jun ^a   Tazawa, Kenji ^b   Fujimaki, Masao ^b   Sato, Yuji ^c   Kondo, Masao ^c   Une, Yoshie ^c   Uchino, Junichi ^c   Saiki, Ikuo ^a  

^a Dept of Pathogenic Biochemistry   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Colon carcinoma; Invasion; L5; Liver metastasis

Indexed keywords

INTEGRIN; MATRIGEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INVASION; COLON CARCINOMA; CONTROLLED STUDY; FEMALE; LIVER METASTASIS; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 8044254000     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1159/000218022     Document Type: Article

References (34)

1. Fidlcr IJ: The Ernst W Bertner Memorial Award Lecture: The evolution of biological heterogeneity in metastatic neoplasmas: in Nicolson GL, Milias L(cds): Cancer Invasion and Metastascs: Biologic and Therapeutic Aspects, Symposium on Fundamental Cancer Research 1983, pp 5-26.
2. Nicolson GL: Tumor cell instability, diversification, and progression to the metastatic phenotype: From oncogene to oncofetal expression, Cancer Res 1987;47:1473-1487.
3. Hart R: ‘Seed and soil' revisited: Mechanisms of sitespecific metastasis, Cancer Metastasis Rev 1982; 1: 5-16.
4. Liotta LA, Rao CV, Barsky SH: Tumor invasion and the extracellular matrix, Lab Invest 1983;49:636- 649.
5. Terranova VP, Hujiancn ES, Martin GR: Basement membrane and the invasive activity of metastatic tumor cells, J Natl Cancer Inst 1986: 77:311-316.
6. McCarthy JB, Furcht LT: Laminin and fibronectin promote the hapto-tactic migration of B16-BL6 mouse melanoma cell in vitro, J Cell Biol 1984;98:1474-1480.
7. Karpathlan S, Pcarlstein E: Heterogenous mechanism of tumor cell-induced platelet aggregation with possible strategy toward prevention of metastasis; in Honn KV, Sloane BF (eds): Hemostasis Mechanisms and Metastasis, Boston, Nijhoff, 1984, pp 139-169.
8. Dingemans KP, Van Spronsen R, Thunnissc E: B16 melanoma meta-sis in mouse liver and lung, Invasion Metastasis 1985;5:50-60.
9. Yukawa H, Nagasuc N, Inokuchi K: Experimental studies on the treatment of nonresectable liver cancer, Jpn J Surg 1981;11:58-65.
10. Izumi B, Tashiro S, Miyauchi Y: Anticancer effects of local administration of mitomycin C via the hepatic artery or portal vein on implantation and growth of VX-2 cancer injected in rabbit liver, Cancer Res 1986;46:4167-4170.
11. Fidler IJ: Selection of successive tumor lines for metastasis, Nature New Biol 1973;242:148-149.
12. Corbett TH, Griswold DP Jr, Roberts BJ, Pcckham JC, Schabel FM Jr: Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure, Cancer Res 1975; 35:2434-2439.
13. Yoo YC, Saiki I, Sato K, Azuma I: MDP-Lys (LI8), a lipophilic deri-vate of muralyl dipeptide, inhibits the metastasis of hacmatogenous and non-hacmatogenous tumours in mice, Vaccine 1994:12:175-180.
14. Saiki I, Matsumoto Y, Murata J, Makabe T, Yoneda J, Okuyama H, Kimizuka F, Ishizak Y, Kato I, Azuma I: Recombinant fusion polypeptide with cell- and heparin-binding domains of fibronectin inhibits liver metastasis of L5178Y-ML25 lymphoma cells, Jpn J Cancer Res 1991; 82:1120-1129.
15. Komazawa H, Saiki I, Aoki M, Kita-guchi H, Satoh H, Kojima M, Ono M, Itoh I, Azuma I: Synthetic Arg-Gly-Asp-Ser analogues of the cell recognition site of fibronectin that retain antimetastatic and anti-cell adhesive properties, Biol Pharm Bull 1993;16:997-1003.
16. Saiki I, Murata J, Watanabe K, Fujii H, Abe F, Azuma I: Inhibition of cell invasion by ubcnimcx (bcstatin) in vitro, Jpn J Cancer Res 1989:80: 873-878.
17. Saiki I, Murata J, Makabe T, Matsumoto Y, Ohdatc Y, Kawase Y, Ta-guchi Y, Shimojo T, Kimizuka F, Kato I, Azuma I: Inhibition of lung metastasis by synthetic and recombinant fragments of human fibron-cctin with functional domains, Jpn J Cancer Res 1990;81:1003-1101.
18. Heussen C, Dowdle EB: Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates, Anal Bio-chem 1980;102:196-202.
19. Liotta LA: Tumor invasion and mc-tastasis-role of the extracellular matrix: Rhoads memorial award lecture, Cancer Res 1986;46:1-7.
20. Stetler-Slevenson WG: Type IV col-lagenases in tumor invasion and metastasis, Cancer Metastasis Rev 1990;9:289-303.
21. Weiss L, Grundmann E, Torhost J, Hartveit F, Mobcrg I, Eder M, Feno-glio-Preiser CM, Napier J, Horne CH, Lopez MJ, Shaw-Dunn RI, Sugar J, Davies JD, DayDW: Hacmatogenous metastasis patterns in colonic carcinoma: An analysis of 1541 necropsies, J Pathol 1986; 150: 195-203.
22. Weiss L, Ward PM: Effects of dis-seminativc route on the liver- and lung-colonizing efficiencies of B16 melanoma and colon-26 carcinoma in mice, Int J Cancer 1989;44:1104- 1107.
23. Fidler IJ: Orthotopic implantation of human colon carcinomas into nude mice provides a valuable model for the biology and therapy of metastasis, Cancer Metastasis Rev 1991;10:229-243.
24. Morikawa K, Walker SM, Jessup JM, Fidler IJ: In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice, Cancer Res 1988; 48:1943-1948.
25. Wilmanns C, Fan D, O’Brian CA, Bucana CD, Fidler IJ: Orthotopic and ectopic organ environments differentially influence the sensitivity of murine colon carcinoma cells to doxorubic n and 5-fiuorouracil, Int J Cancer 1992;52:98-104.
26. Liotta LA, Rao CN, Wcwer UM: Biochemical interactions of tumor cells with the basement membrane, Annu Rev Biochem 1986:55:1037- 1057.
27. Plantefaber LC, Hynes RO: Changes in integrin receptors on on-cogenicallv transformed cells, Cell 1989;56:281-290.
28. Mortarini R, Anichini A, Parmiani G: Heterogeneity for integrin expression and cytokine-mediated VLA modulation can influence the adhesion of human melanoma cells to extracellular matrix proteins, Int J Cancer 1991;47:551-559.
29. Dcdhar S, Saulnier R: Alterations in integrin receptor expression on chemically transformed human cells: Specific enhancement of laminin and collagen receptor complexes, J Cell Biol 1990; 110:481-489.
30. Grey AM, Schor AM, Rushton G, Ellis I, Schor SL: Purification of the migration stimulating factor produced by fetal and breast cancer patient fibroblasts, Proc Natl Acad Sci USA 1989;86:2438-2442.
31. Nabi IR, Watanabe H, Raz A: Identification of B16-F1 melanoma autocrine motility-like factor receptor, Cancer Res 1990;50:409-414.
32. Watanabe H, Carmi P, Kogan V, Raz T, Sillctti S, Nabi IR, Raz A: Purification of human tumor cell autocrine motility factor and molecular cloning of its receptor, J Biol Chem 1991:266:13442-13448.
33. Liotta I.A., Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafic S: Metastatic potential correlates with enzymatic degradation of basement membrane collagen, Nature 1980; 284:67-68.
34. Levy AT, Ciocc V, Sobcl ME, Gar-bisa S, Grigioni WF, Liotta LA, Stetler-Stevenson WG: Increased expression of the Mr 72,000 type IV collagcnase in human colonic adenocarcinoma, Cancer Res 1991:51: 439-444.